Navigation Links
Preventing Strokes With Aspirin

Based on findings of a recent study researchers suggest stroke survivors who stop taking their prescribed daily aspirin // are three-times more likely to have another stroke within the month.

Researchers studied more than 300 stroke or transient ischemic attack (TIA) patients who were on long-term aspirin therapy for preventing subsequent strokes or heart attacks. TIA is a transient stroke that lasts only a few minutes. Researchers also studied a similar population of patients taking aspirin who suffered a stroke more than six months prior. They found 13 patients in the stroke group stopped taking aspirin within four weeks before their stroke, while only four patients who suffered a stroke months earlier did. Patients with stroke or TIA were more than three-times more likely to have interrupted their aspirin regimen than patients with similar risk factors but no new stroke or TIA. Nearly 80 percent of the ischemic strokes related to aspirin discontinuation occurred in the first eight days after aspirin was stopped. The remaining number of patients had ischemic strokes within the month.

In conclusion researchers say though the risk of suffering a substantial stroke during a short period of aspirin discontinuation is probably not very high, the difference is meaningful, and patients and physicians should be informed about the potential risk.
'"/>




Page: 1

Related medicine news :

1. Preventing mental decline in the aged
2. Preventing white coat hypertension
3. Preventing Childhood Deaths
4. Preventing Vision Loss
5. Preventing Vision Loss
6. Preventing Colorectal Cancer
7. Preventing Prostate Cancer
8. Lycopene Can Help In Preventing Prostate Cancer
9. Heart Drug Also Effective In Preventing Specific Causes Of Death
10. Preventing cavities in children
11. Preventing Strokes Using Less Invasive Techniques
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Preventing Strokes With Aspirin

(Date:12/2/2008)... DETROIT, Dec. 2 United ..., which owns and provides comprehensive healthcare...on in Tennessee, today,announced that its Board o...m,authorizing the Company to repurchase up to $1... The program allows for the Company,s common sh...
(Date:12/2/2008)... NEW YORK, Dec. 2 Today...om across the country are coming together at Liz,...or Education to Stop Teen,Dating Abuse. Ann and C...urke,who was murdered by her abusive ex-boyfriend... Redbook magazine on this national coalition that ...
(Date:12/2/2008)... PHILADELPHIA, Dec. 2 Un...vania children the opportunity to become "health,...designing programs to,address it and implementing...dHealth HEROES is a service-learning, health liter..., working through educators and youth,leaders, to...
(Date:12/2/2008)... But too few patients are having the procedure, st...News) -- People with the most common form of epile...ve years of life, and dramatically improved qualit...rain surgery. , That,s the finding of a new stu...benefits of surgery of the temporal lobe region fo...
Breaking Medicine News(10 mins):Health News:United American Healthcare Corporation Announces Stock Repurchase Program 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 2Health News:Parents of Murdered Dating Violence Victim, Legislators, and Teachers Unite to Launch 'MADE' - Moms and Dads for Education to Stop Teen Dating Abuse 3Health News:UnitedHealth Group Grants to Help Students and Educators Combat Childhood Obesity 2Health News:Surgery a Boon for Most Common Form of Epilepsy 2Health News:Surgery a Boon for Most Common Form of Epilepsy 3
...e monitoring device for patients is changing the w...lanted defibrillators//. Rush University Medical ...TITUDE? Patient Management system to determine if ...decrease hospitalizations for heart failure. A mi...
...idly among the rich and educated class in South Af...arkinor Polling// company along with the Universit...aid to be a disease of the poor but it has spread ...gher strata of society too. The reasons cited are ...
...al Health Interview Survey (NHIS) suggest that at ...r scaly skin during the winter months// due to bla...over-heated homes and offices. “Winter is no frie... says Rebecca A. Kazin, M.D., assistant professor ...
...ock Holmes to the hilt when he discovered a link b...ey were using//, and in turn provided material for...pediatric endocrinologist at the University of Col...mother when she brought a her 4 year old son to ge...
Other Medicine News:Health News:Remote Device to Monitor Patients Daily at Their Homes 2Health News:Breast Growth in Boys and Herb Based Products-probable Link, Say Scientists 2
(Date:12/1/2008)...IEGO, Dec. 1 TargeGen has announce...ts from a multi-center, US-based clinical,trial o...has been scheduled at,the 2008 American Society o...the presentation are as follows:, Title: ...ioavailable, JAK2-Selectiv...
(Date:12/1/2008)...Girl with Hypophosphatasia Treated With ENB-0040 a...innipeg , , MONTREAL, Dec. 1 /PRNewswire/ -...any focused on developing novel therapeutics for s...rst infant patient in its clinical program for hyp...nzyme Replacement Therapy (ERT) with ENB-0040 for ...
(Date:12/1/2008)...UTH MEETING, Pa., Dec. 1 ...unced that dosing of subjects has begun in study M...ose Phase 1b study of trodusquemine (MSI-1436) in ... a novel therapeutic for the treatment of type 2 d...pherally to regulate insulin and leptin pathways t...
(Date:12/1/2008)...TA, Dec. 1 GeoVax Labs, ... biotechnology company developing,human vaccines ...cy Virus) and,other infectious agents, announced ...ne Trials will take place in twelve sites across N...d in collaboration with The National Institutes of...
Breaking Medicine Technology:Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 2Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 3Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 4Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease 5Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3Iomai Stockholders Approve Merger With Intercell Subsidiary 6882 1VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 1VIA Pharmaceuticals to Present at 13th Annual IBC Life Sciences Drug Discovery 26 Development of Innovative Therapeutics World Congress 6878 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 1Immune system protein accurate predictor of survival in pediatric septic shock 4305 2Immune system protein accurate predictor of survival in pediatric septic shock 4305 3Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 1Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 2Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 3Bad Backs Essential Shoulder Brace Now Available at badbackstore com 24846 4
....--(BUSINESS WIRE)--Jul 5, 2007 - GTC,Biotherapeut...at,Geoffrey Cox, Ph.D., GTC,s Chairman and CEO, is...at 9:00 a.m. during the C.E.,Unterberg, Towbin Eme...nference is being held at the Mandarin Oriental Ho...The presentation will be webcast live and can be a...
...--(BUSINESS WIRE)--Jul 3, 2007 - EPIX,Pharmaceutic...el G.,Kauffman, M.D., Ph.D., chief executive offic...terberg, Towbin Emerging Growth,Opportunities Conf...) at the Mandarin Oriental Hotel in New York, NY.,...accessed on the,EPIX website, www.epixpharma.com, ...
Other Medicine Technology:GTC Biotherapeutics to Webcast Corporate Presentation at the C.E.,Unterberg, Towbin Emerging Growth Life Opportunities Conference 2EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference 2
Used for temporary internal drainage from the ureteropelvic junction to the bladder. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; C-Flex
Used for catheter or instrument introduction. The dual knobs allow the sheath to be peeled away and removed. The maximum diameter of the catheter or instrument to be introduced should be measured to
Used for antegrade placement of a safety wire guide prior to endourological procedures. Supplied sterile in peel-open packages. Intended for one-time use.
Used to establish a percutaneous tract into the renal pelvis for catheter placement or stone manipulation. Supplied sterile in peel-open packages. Intended for one-time use.
Medicine Products: